Stryker shares tumble despite strong Q2 results and raised guidance
On Thursday, HSBC analyst Frank Lee revised the price target for Arm Holdings stock, traded on (NASDAQ:ARM), increasing it to $115 from the previous target of $105. Despite the raised price target, the firm maintained a Reduce rating on the stock. Currently trading at $173.26, ARM shows significant momentum with a 13.07% gain over the past week, though InvestingPro analysis suggests the stock is trading above its Fair Value.
In the third fiscal quarter of 2025, Arm Holdings reported revenue of $983 million, surpassing both HSBC’s and consensus estimates, which stood at $938 million and $947 million, respectively. This figure also exceeded the company’s own guidance of $945 million. The company maintains impressive profitability with a 95.98% gross margin. Royalty revenue for the quarter was $580 million, closely aligning with the HSBC and consensus projections of $571 million.
The analyst highlighted that the quarter’s revenue beat was primarily due to licensing revenue, which reached $403 million. This figure exceeded HSBC’s and consensus estimates by 7%, coming in at $377 million. According to Lee, licensing revenue continues to provide a positive surprise for Arm Holdings. Notably, the v9 royalty mix remained constant at 25% of total royalties for the quarter, defying earlier expectations that it would increase by 5% quarter-over-quarter. For deeper insights into ARM’s valuation and 16 additional key investment tips, check out the comprehensive analysis available on InvestingPro.
In other recent news, ARM Holdings (LON:ARM) has been the focus of several analyst firms following a robust quarter. UBS maintained a $215 target for the company’s stock, highlighting the AWS Graviton processors’ success and signs of recovery in networking equipment. Evercore ISI raised its price target for ARM to $202, citing a 23% year-over-year increase in royalties and the company’s advantageous position in AI technology integration. JPMorgan also increased its target for ARM to $175, noting the company’s alignment with their investment thesis, which anticipates significant growth driven by gains in market share and deeper penetration into rapidly growing market segments.
Bernstein analysts, while acknowledging the company’s record revenues, maintained their Underperform rating with a steady price target of $100, expressing concerns about the adoption rate of ARM’s v9 technology. Barclays (LON:BARC), on the other hand, kept its Overweight rating with a steady price target of $155, recognizing the company’s strong performance in various sectors, but also pointed out concerns about the stagnation of v9 mix. These are recent developments that highlight the diverse perspectives from different analyst firms regarding ARM Holdings’ performance and prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.